Yu CY - Search Results

1

Hydrogel-based cardiac patches for myocardial infarction therapy: Recent advances and challenges.

Liu Z, Zheng Z, Xie J, Wei H, Yu CY. Liu Z, et al. Among authors: yu cy. Mater Today Bio. 2024 Nov 7;29:101331. doi: 10.1016/j.mtbio.2024.101331. eCollection 2024 Dec. Mater Today Bio. 2024. PMID: 39619639 Free PMC article. Review.

2

In vitro and in vivo evaluation of pectin-based nanoparticles for hepatocellular carcinoma drug chemotherapy.

Yu CY, Wang YM, Li NM, Liu GS, Yang S, Tang GT, He DX, Tan XW, Wei H. Yu CY, et al. Mol Pharm. 2014 Feb 3;11(2):638-44. doi: 10.1021/mp400412c. Epub 2014 Jan 9. Mol Pharm. 2014. PMID: 24383625

3

Cyclodextrin-functionalized polymers as drug carriers for cancer therapy.

Wei H, Yu CY. Wei H, et al. Among authors: yu cy. Biomater Sci. 2015 Jul;3(7):1050-60. doi: 10.1039/c4bm00417e. Epub 2015 Feb 23. Biomater Sci. 2015. PMID: 26221939

4

Delivery of Liver-Specific miRNA-122 Using a Targeted Macromolecular Prodrug toward Synergistic Therapy for Hepatocellular Carcinoma.

Ning Q, Liu YF, Ye PJ, Gao P, Li ZP, Tang SY, He DX, Tang SS, Wei H, Yu CY. Ning Q, et al. Among authors: yu cy. ACS Appl Mater Interfaces. 2019 Mar 20;11(11):10578-10588. doi: 10.1021/acsami.9b00634. Epub 2019 Mar 8. ACS Appl Mater Interfaces. 2019. PMID: 30802029

5

Micelles with Cyclic Poly(ε-caprolactone) Moieties: Greater Stability, Larger Drug Loading Capacity, and Slower Degradation Property for Controlled Drug Release.

Kang G, Sun L, Liu Y, Meng C, Ma W, Wang B, Ma L, Yu C, Wei H. Kang G, et al. Langmuir. 2019 Sep 24;35(38):12509-12517. doi: 10.1021/acs.langmuir.9b02346. Epub 2019 Sep 11. Langmuir. 2019. PMID: 31487459

6

Cell membrane-camouflaged nanoparticles as drug carriers for cancer therapy.

Xu CH, Ye PJ, Zhou YC, He DX, Wei H, Yu CY. Xu CH, et al. Among authors: yu cy. Acta Biomater. 2020 Mar 15;105:1-14. doi: 10.1016/j.actbio.2020.01.036. Epub 2020 Jan 28. Acta Biomater. 2020. PMID: 32001369 Review.

7

Facile Fabrication of Nanoparticles with Dual-Targeting Ligands for Precise Hepatocellular Carcinoma Therapy In Vitro and In Vivo.

Xiang Y, Huang W, Huang C, Long J, Zhou Y, Liu Y, Tang S, He DX, Tan XW, Wei H, Yu CY. Xiang Y, et al. Among authors: yu cy. Mol Pharm. 2020 Sep 8;17(9):3223-3235. doi: 10.1021/acs.molpharmaceut.0c00327. Epub 2020 Jul 27. Mol Pharm. 2020. PMID: 32658485

8

Injectable Hydrogels as Three-Dimensional Network Reservoirs for Osteoporosis Treatment.

Zheng Z, Yu C, Wei H. Zheng Z, et al. Tissue Eng Part B Rev. 2021 Oct;27(5):430-454. doi: 10.1089/ten.TEB.2020.0168. Epub 2020 Nov 25. Tissue Eng Part B Rev. 2021. PMID: 33086984 Review.

9

Peptide-functionalized delivery vehicles for enhanced cancer therapy.

Tang SY, Wei H, Yu CY. Tang SY, et al. Among authors: yu cy. Int J Pharm. 2021 Jan 25;593:120141. doi: 10.1016/j.ijpharm.2020.120141. Epub 2020 Dec 3. Int J Pharm. 2021. PMID: 33279713 Review.

10

Folate-Targeted Anticancer Drug Delivery via a Combination Strategy of a Micelle Complex and Reducible Conjugation.

Wang M, Long J, Zhang S, Liu F, Zhang X, Zhang X, Sun L, Ma L, Yu C, Wei H. Wang M, et al. ACS Biomater Sci Eng. 2020 Mar 9;6(3):1565-1572. doi: 10.1021/acsbiomaterials.9b01920. Epub 2020 Feb 25. ACS Biomater Sci Eng. 2020. PMID: 33455375

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,194 results

Search Page

Filters